Welcome to LookChem.com Sign In|Join Free

CAS

  • or

1191-69-1

Post Buying Request

1191-69-1 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

1191-69-1 Usage

Description

Decyl isocyanate, a linear alkyl isocyanate, is synthesized from decylamine and is known for its potential applications in the synthesis of proteasome inhibitors. These inhibitors are essential in various fields, including pharmaceuticals and biotechnology, due to their ability to modulate cellular processes and target specific diseases.

Uses

Used in Pharmaceutical Industry:
Decyl isocyanate is used as a key intermediate compound for the synthesis of proteasome inhibitors, which play a crucial role in the development of novel therapeutic agents. These inhibitors target the proteasome, a cellular protein complex responsible for the degradation of unneeded or damaged proteins, and have shown potential in treating various diseases, including cancer and neurodegenerative disorders.
1. DECYL ISOCYANATE 98 is used as a precursor for the synthesis of proteasome inhibitors for targeting the proteasome in the treatment of diseases like cancer and neurodegenerative disorders.
2. DECYL ISOCYANATE 98 is used as a building block for the development of potential proteasome inhibitors such as decyl-urea-Val-NHNHBoc, decyl-urea-Val-Leu2-VS, and decyl-urea-Val-Leu2-EK, which are designed to modulate cellular processes and target specific diseases.
Used in Biotechnology Industry:
Decyl isocyanate is utilized in the development of innovative biotechnological applications, where proteasome inhibitors can be employed to study the role of the proteasome in cellular processes and to develop new strategies for disease management.
1. DECYL ISOCYANATE 98 is used as a starting material for the creation of proteasome inhibitors in biotechnological research to understand the proteasome's role in cellular functions and develop new therapeutic approaches.
2. DECYL ISOCYANATE 98 is used as a component in the design and synthesis of proteasome inhibitors for biotechnological applications, aiming to improve the understanding of disease mechanisms and the development of targeted therapies.

Check Digit Verification of cas no

The CAS Registry Mumber 1191-69-1 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 1,1,9 and 1 respectively; the second part has 2 digits, 6 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 1191-69:
(6*1)+(5*1)+(4*9)+(3*1)+(2*6)+(1*9)=71
71 % 10 = 1
So 1191-69-1 is a valid CAS Registry Number.
InChI:InChI=1/C11H21NO/c1-2-3-4-5-6-7-8-9-10-12-11-13/h2-10H2,1H3

1191-69-1 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail
  • Aldrich

  • (556270)  Decylisocyanate  98%

  • 1191-69-1

  • 556270-25G

  • 5,496.66CNY

  • Detail

1191-69-1SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 17, 2017

Revision Date: Aug 17, 2017

1.Identification

1.1 GHS Product identifier

Product name 1-isocyanatodecane

1.2 Other means of identification

Product number -
Other names Decylisocyanat

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:1191-69-1 SDS

1191-69-1Relevant articles and documents

New lipophilic isoniazid derivatives and their 1,3,4-oxadiazole analogues: Synthesis, antimycobacterial activity and investigation of their mechanism of action

Vosátka, Rudolf,Krátky, Martin,?varcová, Markéta,Janou?ek, Ji?í,Stola?íková, Ji?ina,Madacki, Jan,Huszár, Stanislav,Miku?ová, Katarína,Korduláková, Jana,Trejtnar, Franti?ek,Vin?ová, Jarmila

, p. 824 - 835 (2018)

The development of novel drugs is essential for the treatment of tuberculosis and other mycobacterial infections in future. A series of N-alkyl-2-isonicotinoylhydrazine-1-carboxamides was synthesized from isoniazid (INH) and then cyclized to N-alkyl-5-(pyridin-4-yl)-1,3,4-oxadiazole-2-amines. All derivatives were characterised spectroscopically. The compounds were screened for their in vitro antimycobacterial activity against susceptible and multidrug-resistant Mycobacterium tuberculosis (Mtb.) and nontuberculous mycobacteria (NTM; M. avium, M. kansasii). The most active carboxamides were substituted by a short n-alkyl, their activity was comparable to INH with minimum inhibitory concentrations (MICs) against Mtb. of 0.5–2 μM. Moreover, they are non-toxic for HepG2, and some of them are highly active against INH-resistant NTM (MICs ≥4 μM). Their cyclization to 1,3,4-oxadiazoles did not increase the activity. The experimentally proved mechanism of action of 2-isonicotinoylhydrazine-1-carboxamides consists of the inhibition of enoyl-ACP reductase (InhA) in a way similar to INH, which is blocking the biosynthesis of mycolic acids. N-Dodecyl-5-(pyridin-4-yl)-1,3,4-oxadiazol-2-amine as the most efficacious oxadiazole inhibits growth of both susceptible and drug-resistant Mtb. strains with uniform MIC values of 4–8 μM with no cross-resistance to antitubercular drugs including INH. The mechanism of action is not elucidated but it is different from INH. Obtained results qualify these promising derivatives for further investigation.

Triaminoformate long-carbon-chain organosilane quaternary ammonium salt compound as well as preparation and application thereof

-

Paragraph 0037; 0039, (2019/07/04)

The invention relates to a triaminoformate long carbon chain organosilane quaternary ammonium salt compound as well as preparation and an application thereof. The structure of the compound is shown ina general formula (I). The preparation method comprises the following steps: firstly, using long-chain aliphatic amine as a raw material to prepare long-carbon-chain isocyanate in an organic solvent;reacting the long-carbon-chain isocyanate with triethanolamine in an organic solvent, and carrying out recrystallization to obtain a triaminoformate fatty chain intermediate; and reacting the obtained intermediate with haloalkyl trimethoxysilane to obtain an organosilane quaternary ammonium salt compound. The organosilane quaternary ammonium salt compound can be applied to preparation of a hierarchical pore ZSM-5 zeolite molecular sieve. The obtained hierarchical pore channel ZSM-5 zeolite molecular sieve is beneficial to diffusion of macromolecular reactants and products, and has a potentialapplication prospect in macromolecular reaction catalysis.

Discovery of a potent and highly β1 specific proteasome inhibitor from a focused library of urea-containing peptide vinyl sulfones and peptide epoxyketones

Van Der Linden, Wouter A.,Willems, Lianne I.,Shabaneh, Tamer B.,Li, Nan,Ruben, Mark,Florea, Bogdan I.,Van Der Marel, Gijs A.,Kaiser, Markus,Kisselev, Alexei F.,Overkleeft, Herman S.

experimental part, p. 181 - 194 (2012/01/12)

Syringolins, a class of natural products, potently and selectively inhibit the proteasome and show promising antitumour activity. To gain insight in the mode of action of syringolins, the ureido structural element present in syringolins is incorporated in

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 1191-69-1